Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p75NTR is a type I transmembrane glycoprotein receptor belonging to the tumor necrosis factor receptor (TNFR) superfamily. It acts as a pan-neurotrophin receptor, binding all neurotrophins and their proforms. p75NTR plays crucial roles in regulating cell death and survival, neuronal development, tissue remodeling, energy expenditure, hypoxic response, scar formation, and neurodegeneration. It's a key regulator of cell fate, influencing survival, apoptosis, neurite outgrowth and synaptic plasticity. The outcome of p75NTR activation depends on the specific ligand bound (mature vs. proneurotrophins), presence of co-receptors such as TrkA/B/C or sortilin, and the cellular context. Therapeutic targeting of p75NTR is under investigation for neurological disorders.
Modulation of pro-survival/pro-apoptotic functions via peptides/small molecules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nerve Growth Factor Receptor p75NTR (p75NTR).